Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Diclofenac as a Non-Selective COX Inhibitor for Intestina...
2025-09-30
Harness Diclofenac’s robust cyclooxygenase inhibition in advanced human iPSC-derived intestinal organoid models for next-generation anti-inflammatory and pharmacokinetic studies. This guide details experimental workflows, optimization strategies, and troubleshooting tips to elevate inflammation and pain signaling research beyond conventional cell lines.
-
Pseudo-Modified Uridine Triphosphate: Engineered for Next...
2025-09-29
Explore the advanced role of pseudo-modified uridine triphosphate (Pseudo-UTP) in enhancing RNA stability, translation, and immunogenicity control for mRNA vaccine development. Discover new scientific insights and practical strategies for deploying Pseudo-UTP in precision RNA therapeutics.
-
A 83-01: Next-Generation ALK-5 Inhibitor for Human Organo...
2025-09-28
Explore the role of A 83-01 as a selective TGF-β type I receptor inhibitor in advancing pharmacokinetic studies with human stem cell-derived organoids. This deep-dive highlights unique mechanistic insights and translational applications beyond conventional EMT or fibrosis research.
-
CHIR 99021 Trihyd
2025-09-27
Explore the advanced role of CHIR 99021 trihydrochloride, a potent GSK-3 inhibitor, in orchestrating tunable organoid systems and dynamic stem cell differentiation. This article offers a unique systems biology perspective on serine/threonine kinase inhibition and its transformative impact on metabolic, diabetes, and cancer research.
-
EZ Cap™ Firefly Luciferase mRNA (5-moUTP): Next-Gen Biolu...
2025-09-26
Explore the scientific advances and translational applications of EZ Cap™ Firefly Luciferase mRNA (5-moUTP), a leading in vitro transcribed capped mRNA for sensitive bioluminescent reporter gene assays. This article uniquely examines its molecular design, immune modulation, and in vivo imaging utility beyond standard assay optimization.
-
2'3'-cGAMP (sodium salt): Decoding Cell-Type Specificity ...
2025-09-25
Uncover the unique role of 2'3'-cGAMP (sodium salt) in dissecting cell-type specific STING activation and type I interferon induction. This article offers a deep dive into advanced experimental strategies and translational implications for cancer immunotherapy and antiviral research.
-
Annexin V: Decoding Early Apoptosis in Immune-Imbalance M...
2025-09-24
Explore how Annexin V, a leading apoptosis detection reagent, enables high-resolution insight into early apoptosis and immune regulation—revealing new frontiers in cell death research and disease modeling. Uncover advanced strategies distinct from prior guides.
-
X-press Tag Peptide: Optimizing Tag Design for Advanced P...
2025-09-23
Explore the unique molecular features of X-press Tag Peptide as an N-terminal leader peptide designed for precise protein purification. This article details its integration with affinity purification systems and discusses best practices for peptide solubility and storage to ensure reproducible results in recombinant protein expression.
-
br Introduction There are greater than
2025-03-03

Introduction There are greater than five million Americans living with Alzheimer's dementia and more than 35 million people worldwide [1], and without a way to stop or slow the progression, there will be nearly a tripling of individuals affected by 2050 (13.8 million) [1]. The urgency to develop
-
Mt a known to be upregulated
2025-03-03

Mt2a, known to be upregulated by ozone (Inoue et al., 2008), was also increased in vehicle-pretreated rats exposed to ozone, however, this effect was markedly reduced by both PROP and MIFE, suggesting that the neuroendocrine response is linked to ozone-induced acute phase protein expression. In huma
-
A previous study reported that the
2025-03-03

A previous study reported that the serotonergic mechanism was involved in the psychological stress-induced alteration in synaptic plasticity in the rat hippocampal CA1 field (Matsumoto et al., 2004). Sumitaka Inoue et al. (Inoue et al., 2014) reported that pretreatment with a 5-HT1A receptor partial
-
AdK as an important upstream
2025-03-03

AdK as an important upstream regulator of adenosine-based homeostasis represents a promising drug target since it leads to an increase in adenosine concentrations. Taking into account that the adenosine formation is only increased in affected tissues under stress with high adenosine levels, AdK inhi
-
br Acknowledgments The authors would
2025-03-03

Acknowledgments The authors would like to thank Ms. Ashley Davis for her administrative assistance in preparing this article and Mr. Dan Beck for his artistic contributions to Fig. 1. Introduction Acetylcholine is the most abundant neurotransmitter in the central nervous system (CNS) of insec
-
Our analysis has devoted limited attention to the standard
2025-03-03

Our analysis has devoted limited attention to the standard corporate tax scheme with deductibility for interest payments that is in place in most countries. A conventional corporate tax scheme offers partial deduction of capital costs, and can be interpreted as a change in the degree of capital cost
-
3576 It is already established in the literature that produc
2025-03-03

It is already established in the literature that products synthesized by 5-LO, such as lipoxin A4, can activate PPARγ in a setting of experimental stroke [43]. Interestingly, experiments using 5-LO knockout mice in an endotoxemia model to mimic septic conditions, demonstrated reduced multiple organ
16378 records 25/1092 page Previous Next First page 上5页 2122232425 下5页 Last page